Osmak, M., Babič, D., Abramič, M., Miličič, D., Vrhovec, I., & Škrk, J. Plasminogen activator inhibitor type 2: Potential prognostic factor for endometrial carcinomas.
Chicago Style (17th ed.) CitationOsmak, M., D. Babič, M. Abramič, D. Miličič, I. Vrhovec, and J. Škrk. Plasminogen Activator Inhibitor Type 2: Potential Prognostic Factor for Endometrial Carcinomas.
MLA (9th ed.) CitationOsmak, M., et al. Plasminogen Activator Inhibitor Type 2: Potential Prognostic Factor for Endometrial Carcinomas.
Warning: These citations may not always be 100% accurate.
